X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PFIZER - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PFIZER STERLING BIOTECH/
PFIZER
 
P/E (TTM) x -1.8 23.8 - View Chart
P/BV x 0.1 3.8 1.8% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 STERLING BIOTECH   PFIZER
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PFIZER
Mar-16
STERLING BIOTECH/
PFIZER
5-Yr Chart
Click to enlarge
High Rs112,724 0.4%   
Low Rs31,611 0.2%   
Sales per share (Unadj.) Rs26.8440.9 6.1%  
Earnings per share (Unadj.) Rs-15.048.7 -30.7%  
Cash flow per share (Unadj.) Rs-5.575.8 -7.2%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs54.9462.9 11.9%  
Shares outstanding (eoy) m267.8745.75 585.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.9 5.3%   
Avg P/E ratio x-0.544.5 -1.0%  
P/CF ratio (eoy) x-1.328.6 -4.4%  
Price / Book Value ratio x0.14.7 2.7%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m1,86299,163 1.9%   
No. of employees `0001.42.9 46.9%   
Total wages/salary Rs m5472,758 19.8%   
Avg. sales/employee Rs Th5,303.36,981.7 76.0%   
Avg. wages/employee Rs Th403.8954.5 42.3%   
Avg. net profit/employee Rs Th-2,959.0771.1 -383.7%   
INCOME DATA
Net Sales Rs m7,18120,170 35.6%  
Other income Rs m43857 5.0%   
Total revenues Rs m7,22321,028 34.4%   
Gross profit Rs m9474,310 22.0%  
Depreciation Rs m2,5431,239 205.3%   
Interest Rs m4,3775 84,175.0%   
Profit before tax Rs m-5,9313,923 -151.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m-1,9241,794 -107.2%   
Profit after tax Rs m-4,0072,228 -179.8%  
Gross profit margin %13.221.4 61.7%  
Effective tax rate %32.445.7 70.9%   
Net profit margin %-55.811.0 -505.2%  
BALANCE SHEET DATA
Current assets Rs m14,33516,299 88.0%   
Current liabilities Rs m49,8097,594 655.9%   
Net working cap to sales %-494.043.2 -1,144.7%  
Current ratio x0.32.1 13.4%  
Inventory Days Days40365 618.0%  
Debtors Days Days17126 662.7%  
Net fixed assets Rs m55,4328,622 642.9%   
Share capital Rs m268458 58.6%   
"Free" reserves Rs m13,93520,722 67.2%   
Net worth Rs m14,70121,180 69.4%   
Long term debt Rs m9,47825 37,911.4%   
Total assets Rs m73,98829,137 253.9%  
Interest coverage x-0.4755.5 -0.0%   
Debt to equity ratio x0.60 54,618.5%  
Sales to assets ratio x0.10.7 14.0%   
Return on assets %0.57.7 6.5%  
Return on equity %-27.310.5 -259.1%  
Return on capital %-6.419.0 -33.8%  
Exports to sales %25.90.1 43,533.9%   
Imports to sales %0.217.5 1.0%   
Exports (fob) Rs m1,86012 15,498.3%   
Imports (cif) Rs m123,526 0.3%   
Fx inflow Rs m1,86052 3,600.8%   
Fx outflow Rs m25140 17.8%   
Net fx Rs m1,835-88 -2,077.3%   
CASH FLOW
From Operations Rs m1,7193,436 50.0%  
From Investments Rs m-3,148-6,991 45.0%  
From Financial Activity Rs m1,426-619 -230.4%  
Net Cashflow Rs m-3-4,174 0.1%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 9.9 4.9 202.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 23.7 165.8%  
Shareholders   21,482 85,207 25.2%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  SUVEN LIFE  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 22, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS